Singapore, Sept. 3 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-Label, Multicenter, Phase 3 Study to Investigate Mocertatug Rezetecan with Beva... Read More
U.S., Sept. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07800468) titled 'Efficacy of Topical Lidocaine Gel vs. Oral Duloxetine for Painful Diabetic Peripheral Neuro... Read More
Singapore, Sept. 3 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-Label, Phase 3 Study of Rinatabart Sesutecan (Rina-S) Plus Standard of Care Ver... Read More
Singapore, Sept. 3 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-Label Phase 3 Study of Azenosertib Versus Investigator’s Choice of Chemotherapy... Read More
Singapore, Sept. 3 -- The Health Sciences Authority received information related to the study titled 'A single-ascending and multiple-ascending dose study to evaluate the safety, tolerability, pharmac... Read More
Singapore, Sept. 3 -- The Health Sciences Authority received information related to the study titled 'An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembr... Read More
Singapore, Sept. 3 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Ef... Read More
U.S., Sept. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07799831) titled 'Oral Health, Saliva Bacteria, and Disease Activity in Children With JIA: A Cross-Sectional ... Read More
U.S., Sept. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07799974) titled 'Identification of Changes in Cancer-related Fatigue and Physical Activity and Their Associa... Read More
Singapore, Sept. 3 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Pl... Read More